Evidence of cellular nicotinic receptor desensitization in rats exhibiting nicotine-induced acute tolerance
Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs). To determine the relationship between in vivo pharmacological desensitization...
Saved in:
Published in | Psychopharmacology Vol. 184; no. 3-4; pp. 306 - 313 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Springer Nature B.V
01.02.2006
|
Subjects | |
Online Access | Get full text |
ISSN | 0033-3158 1432-2072 |
DOI | 10.1007/s00213-005-0049-9 |
Cover
Abstract | Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs).
To determine the relationship between in vivo pharmacological desensitization (in other words, acute tolerance) and brain regional nAChR function.
Male Sprague-Dawley rats, trained to discriminate nicotine (0.4 mg/kg free base) from saline in a two-lever drug discrimination task, were tested for the development of acute tolerance. Rats were injected with 0.4 mg/kg nicotine, tested for nicotine discrimination for 2 min, then injected with the same dose of nicotine 90 min, 180 min, and 270 min after the first injection and tested for nicotine discrimination after each injection. These subjects were separated into two groups, desensitizers (DZ) and nondesensitizers (NDZ), based upon performance in the repetitive dosing drug discrimination paradigm. The sensitivity of nAChRs in specific brain regions of these two groups was assessed by the use of an 86Rb+ efflux assay using synaptosomes prepared from the frontal cortex, hippocampus, striatum, and "thalamus," which included the midbrain and hypothalamus as well as the thalamus.
The nicotine-induced increase in 86Rb+ efflux was significantly greater in NDZ as compared to DZ in the "thalamus." There was no statistically significant difference in the effects of nicotine in the frontal cortex, hippocampus, and striatum of these two groups. A significant correlation was observed between thalamic 86Rb+ efflux and the rate of behavioral desensitization of individual rats.
These findings are consistent with the concept that the production of acute tolerance by nicotine in vivo correlates directly with its ability to induce nAChR desensitization at the cellular level. |
---|---|
AbstractList | Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs).RATIONALEIndividuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs).To determine the relationship between in vivo pharmacological desensitization (in other words, acute tolerance) and brain regional nAChR function.OBJECTIVETo determine the relationship between in vivo pharmacological desensitization (in other words, acute tolerance) and brain regional nAChR function.Male Sprague-Dawley rats, trained to discriminate nicotine (0.4 mg/kg free base) from saline in a two-lever drug discrimination task, were tested for the development of acute tolerance. Rats were injected with 0.4 mg/kg nicotine, tested for nicotine discrimination for 2 min, then injected with the same dose of nicotine 90 min, 180 min, and 270 min after the first injection and tested for nicotine discrimination after each injection. These subjects were separated into two groups, desensitizers (DZ) and nondesensitizers (NDZ), based upon performance in the repetitive dosing drug discrimination paradigm. The sensitivity of nAChRs in specific brain regions of these two groups was assessed by the use of an 86Rb+ efflux assay using synaptosomes prepared from the frontal cortex, hippocampus, striatum, and "thalamus," which included the midbrain and hypothalamus as well as the thalamus.METHODSMale Sprague-Dawley rats, trained to discriminate nicotine (0.4 mg/kg free base) from saline in a two-lever drug discrimination task, were tested for the development of acute tolerance. Rats were injected with 0.4 mg/kg nicotine, tested for nicotine discrimination for 2 min, then injected with the same dose of nicotine 90 min, 180 min, and 270 min after the first injection and tested for nicotine discrimination after each injection. These subjects were separated into two groups, desensitizers (DZ) and nondesensitizers (NDZ), based upon performance in the repetitive dosing drug discrimination paradigm. The sensitivity of nAChRs in specific brain regions of these two groups was assessed by the use of an 86Rb+ efflux assay using synaptosomes prepared from the frontal cortex, hippocampus, striatum, and "thalamus," which included the midbrain and hypothalamus as well as the thalamus.The nicotine-induced increase in 86Rb+ efflux was significantly greater in NDZ as compared to DZ in the "thalamus." There was no statistically significant difference in the effects of nicotine in the frontal cortex, hippocampus, and striatum of these two groups. A significant correlation was observed between thalamic 86Rb+ efflux and the rate of behavioral desensitization of individual rats.RESULTSThe nicotine-induced increase in 86Rb+ efflux was significantly greater in NDZ as compared to DZ in the "thalamus." There was no statistically significant difference in the effects of nicotine in the frontal cortex, hippocampus, and striatum of these two groups. A significant correlation was observed between thalamic 86Rb+ efflux and the rate of behavioral desensitization of individual rats.These findings are consistent with the concept that the production of acute tolerance by nicotine in vivo correlates directly with its ability to induce nAChR desensitization at the cellular level.CONCLUSIONThese findings are consistent with the concept that the production of acute tolerance by nicotine in vivo correlates directly with its ability to induce nAChR desensitization at the cellular level. Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs). To determine the relationship between in vivo pharmacological desensitization (in other words, acute tolerance) and brain regional nAChR function. Male Sprague-Dawley rats, trained to discriminate nicotine (0.4 mg/kg free base) from saline in a two-lever drug discrimination task, were tested for the development of acute tolerance. Rats were injected with 0.4 mg/kg nicotine, tested for nicotine discrimination for 2 min, then injected with the same dose of nicotine 90 min, 180 min, and 270 min after the first injection and tested for nicotine discrimination after each injection. These subjects were separated into two groups, desensitizers (DZ) and nondesensitizers (NDZ), based upon performance in the repetitive dosing drug discrimination paradigm. The sensitivity of nAChRs in specific brain regions of these two groups was assessed by the use of an 86Rb+ efflux assay using synaptosomes prepared from the frontal cortex, hippocampus, striatum, and "thalamus," which included the midbrain and hypothalamus as well as the thalamus. The nicotine-induced increase in 86Rb+ efflux was significantly greater in NDZ as compared to DZ in the "thalamus." There was no statistically significant difference in the effects of nicotine in the frontal cortex, hippocampus, and striatum of these two groups. A significant correlation was observed between thalamic 86Rb+ efflux and the rate of behavioral desensitization of individual rats. These findings are consistent with the concept that the production of acute tolerance by nicotine in vivo correlates directly with its ability to induce nAChR desensitization at the cellular level. Issue Title: Nicotine Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs). To determine the relationship between in vivo pharmacological desensitization (in other words, acute tolerance) and brain regional nAChR function. Male Sprague-Dawley rats, trained to discriminate nicotine (0.4 mg/kg free base) from saline in a two-lever drug discrimination task, were tested for the development of acute tolerance. Rats were injected with 0.4 mg/kg nicotine, tested for nicotine discrimination for 2 min, then injected with the same dose of nicotine 90 min, 180 min, and 270 min after the first injection and tested for nicotine discrimination after each injection. These subjects were separated into two groups, desensitizers (DZ) and nondesensitizers (NDZ), based upon performance in the repetitive dosing drug discrimination paradigm. The sensitivity of nAChRs in specific brain regions of these two groups was assessed by the use of an 86Rb+ efflux assay using synaptosomes prepared from the frontal cortex, hippocampus, striatum, and "thalamus," which included the midbrain and hypothalamus as well as the thalamus. The nicotine-induced increase in 86Rb+ efflux was significantly greater in NDZ as compared to DZ in the "thalamus." There was no statistically significant difference in the effects of nicotine in the frontal cortex, hippocampus, and striatum of these two groups. A significant correlation was observed between thalamic 86Rb+ efflux and the rate of behavioral desensitization of individual rats. These findings are consistent with the concept that the production of acute tolerance by nicotine in vivo correlates directly with its ability to induce nAChR desensitization at the cellular level. [PUBLICATION ABSTRACT] Rationale: Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs). Objective: To determine the relationship between in vivo pharmacological desensitization (in other words, acute tolerance) and brain regional nAChR function. Methods: Male Sprague-Dawley rats, trained to discriminate nicotine (0.4 mg/kg free base) from saline in a two-lever drug discrimination task, were tested for the development of acute tolerance. Rats were injected with 0.4 mg/kg nicotine, tested for nicotine discrimination for 2 min, then injected with the same dose of nicotine 90 min, 180 min, and 270 min after the first injection and tested for nicotine discrimination after each injection. These subjects were separated into two groups, desensitizers (DZ) and nondesensitizers (NDZ), based upon performance in the repetitive dosing drug discrimination paradigm. The sensitivity of nAChRs in specific brain regions of these two groups was assessed by the use of an super(86)Rb super(+) efflux assay using synaptosomes prepared from the frontal cortex, hippocampus, striatum, and 'thalamus,' which included the midbrain and hypothalamus as well as the thalamus. Results: The nicotine-induced increase in super(86)Rb super(+) efflux was significantly greater in NDZ as compared to DZ in the 'thalamus.' There was no statistically significant difference in the effects of nicotine in the frontal cortex, hippocampus, and striatum of these two groups. A significant correlation was observed between thalamic super(86)Rb super(+) efflux and the rate of behavioral desensitization of individual rats. Conclusion: These findings are consistent with the concept that the production of acute tolerance by nicotine in vivo correlates directly with its ability to induce nAChR desensitization at the cellular level. Rationale: Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs). Objective: To determine the relationship between in vivo pharmacological desensitization (in other words, acute tolerance) and brain regional nAChR function. Methods: Male Sprague-Dawley rats, trained to discriminate nicotine (0.4mg/kg free base) from saline in a two-lever drug discrimination task, were tested for the development of acute tolerance. Rats were injected with 0.4mg/kg nicotine, tested for nicotine discrimination for 2min, then injected with the same dose of nicotine 90min, 180min, and 270min after the first injection and tested for nicotine discrimination after each injection. These subjects were separated into two groups, desensitizers (DZ) and nondesensitizers (NDZ), based upon performance in the repetitive dosing drug discrimination paradigm. The sensitivity of nAChRs in specific brain regions of these two groups was assessed by the use of an super(86)Rb super(+) efflux assay using synaptosomes prepared from the frontal cortex, hippocampus, striatum, and "thalamus," which included the midbrain and hypothalamus as well as the thalamus. Results: The nicotine-induced increase in super(86)Rb super(+) efflux was significantly greater in NDZ as compared to DZ in the "thalamus." There was no statistically significant difference in the effects of nicotine in the frontal cortex, hippocampus, and striatum of these two groups. A significant correlation was observed between thalamic super(86)Rb super(+) efflux and the rate of behavioral desensitization of individual rats. Conclusion: These findings are consistent with the concept that the production of acute tolerance by nicotine in vivo correlates directly with its ability to induce nAChR desensitization at the cellular level. |
Author | James, John R. Philibin, Scott D. Rosecrans, John A. Gross, Daniel F. Lapp, Laura N. Vann, Robert E. Robinson, Susan E. |
Author_xml | – sequence: 1 givenname: Susan E. surname: Robinson fullname: Robinson, Susan E. – sequence: 2 givenname: John R. surname: James fullname: James, John R. – sequence: 3 givenname: Laura N. surname: Lapp fullname: Lapp, Laura N. – sequence: 4 givenname: Robert E. surname: Vann fullname: Vann, Robert E. – sequence: 5 givenname: Daniel F. surname: Gross fullname: Gross, Daniel F. – sequence: 6 givenname: Scott D. surname: Philibin fullname: Philibin, Scott D. – sequence: 7 givenname: John A. surname: Rosecrans fullname: Rosecrans, John A. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16010542$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkcFOHSEUhkljU6-2D9CNIV20q2kPMAzDsjFaTUy6adeEYc4odi5cgTFtn16uV2PiQkmAhHz_IX--A7IXYkBCPjL4ygDUtwzAmWgAZN2tbvQbsmKt4A0HxffICkCIRjDZ75ODnK-hrrZv35F91gED2fIV-XNy60cMDmmcqMN5XmabaPAuFl9PmtDhpsRER8wYsi_-vy0-BuoDTbZkin-v_FCfw-VjChsfxsXhSK1bCtISZ0y2fvGevJ3snPHDw31Ifp-e_Do-ay5-_jg__n7RONHr0mg7dE5xcIMTHFoltOLDqDqctMbBCmFVO_UAE68VRMeV1XpEJiUMvR6FFYfky27uJsWbBXMxa5-33WzAuGSjZCul0hIq-flFslNdp4F3r4JM817x-4mfnoHXcUmh1jWc9VpJDn2Fjh6gZVjjaDbJr236Zx61VIDtAJdizgmnJwTMVr3ZqTdVvdmqN7pm1LOM8-XeVUnWzy8k7wBBdLI8 |
CitedBy_id | crossref_primary_10_1002_ddr_20219 crossref_primary_10_1177_0269881118822074 crossref_primary_10_1016_j_brainres_2006_07_110 crossref_primary_10_1007_s00213_012_2814_x crossref_primary_10_1007_s00213_006_0687_6 crossref_primary_10_1038_sj_npp_1301455 crossref_primary_10_1016_j_brainresbull_2011_05_011 crossref_primary_10_1016_j_neubiorev_2009_07_013 crossref_primary_10_1146_annurev_pharmtox_47_120505_105354 crossref_primary_10_2139_ssrn_4183131 crossref_primary_10_1038_oby_2008_221 crossref_primary_10_1016_j_brainres_2014_02_038 crossref_primary_10_1016_j_drugalcdep_2023_110900 crossref_primary_10_1016_j_yhbeh_2009_10_003 crossref_primary_10_1124_jpet_121_000978 crossref_primary_10_1016_j_nlm_2012_04_003 crossref_primary_10_1016_j_pbb_2008_01_018 crossref_primary_10_3390_toxics10110696 |
Cites_doi | 10.1016/0740-5472(93)90041-Y 10.1002/(SICI)1098-2299(199607/08)38:3/4<222::AID-DDR11>3.0.CO;2-0 10.1016/0091-3057(81)90332-4 10.1016/S0169-328X(03)00171-2 10.1111/j.1749-6632.2002.tb04177.x 10.1007/BF00713026 10.1016/S0166-4328(00)00205-9 10.1037/0022-006X.61.5.723 10.1002/neu.10109 10.1016/S0166-4328(00)00198-4 10.1016/0165-6147(91)90638-9 10.1016/S0079-6123(08)62483-8 10.1007/BF02249336 10.1007/BF02245835 10.1124/mol.62.2.334 10.1007/BF00421360 10.1046/j.1471-4159.1994.63020561.x 10.1007/BF00429192 10.1523/JNEUROSCI.18-12-04461.1998 10.1113/jphysiol.1957.sp005838 10.1016/0376-8716(85)90077-8 10.1046/j.1471-4159.1994.63062125.x 10.1016/0166-4328(95)00245-6 10.1016/0361-9230(95)00007-0 10.1111/j.1471-4159.1985.tb04005.x 10.1007/978-1-4612-4974-0 10.1523/JNEUROSCI.19-12-04804.1999 |
ContentType | Journal Article |
Copyright | Springer-Verlag 2006 |
Copyright_xml | – notice: Springer-Verlag 2006 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 88G 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ K9. KB0 M0S M1P M2M NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7U7 C1K 7X8 |
DOI | 10.1007/s00213-005-0049-9 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Chemoreception Abstracts Nursing & Allied Health Database Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Psychology Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Animal Behavior Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest One Psychology Toxicology Abstracts Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1432-2072 |
EndPage | 313 |
ExternalDocumentID | 1440233431 16010542 10_1007_s00213_005_0049_9 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United States--US Virginia |
GeographicLocations_xml | – name: United States--US – name: Virginia |
GroupedDBID | .55 3SX 40D 40E 95. 95~ AAYXX ABMNI AGWIL ALMA_UNASSIGNED_HOLDINGS CITATION KOW N2Q R9- RHV SBY SOJ X7M ~EX -4W -BR CGR CUY CVF ECM EIF NPM 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GNUQQ K9. M1P M2M NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7U7 C1K 7X8 |
ID | FETCH-LOGICAL-c389t-9ab6c720cbc320473972bd76ef99eba33a74f800f20543627a99de1550b89d3a3 |
IEDL.DBID | 7X7 |
ISSN | 0033-3158 |
IngestDate | Fri Jul 11 12:30:17 EDT 2025 Thu Jul 10 22:32:13 EDT 2025 Fri Jul 11 06:12:32 EDT 2025 Thu Aug 14 11:22:24 EDT 2025 Sat Sep 28 07:44:59 EDT 2024 Thu Apr 24 22:52:11 EDT 2025 Tue Jul 01 00:39:55 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3-4 |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c389t-9ab6c720cbc320473972bd76ef99eba33a74f800f20543627a99de1550b89d3a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 16010542 |
PQID | 218975208 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_754557950 proquest_miscellaneous_67669026 proquest_miscellaneous_19287250 proquest_journals_218975208 pubmed_primary_16010542 crossref_primary_10_1007_s00213_005_0049_9 crossref_citationtrail_10_1007_s00213_005_0049_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2006-02-01 |
PublicationDateYYYYMMDD | 2006-02-01 |
PublicationDate_xml | – month: 02 year: 2006 text: 2006-02-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany – name: Heidelberg |
PublicationTitle | Psychopharmacology |
PublicationTitleAlternate | Psychopharmacology (Berl) |
PublicationYear | 2006 |
Publisher | Springer Nature B.V |
Publisher_xml | – name: Springer Nature B.V |
References | MJ Marks (49_CR10) 1993; 264 JR James (49_CR7) 1994; 114 BM Sharp (49_CR29) 1986; 238 IP Stolerman (49_CR31) 1991; 12 ID Hirschhorn (49_CR5) 1974; 40 M Shoaib (49_CR30) 1996; 78 ELM Ochoa (49_CR18) 1989; 9 JA Rosecrans (49_CR23) 1991; 116 PP Rowell (49_CR27) 1994; 63 CP Fenster (49_CR4) 1999; 19 H Miyata (49_CR14) 2002; 965 T Nishizaki (49_CR16) 2003; 114 IP Stolerman (49_CR32) 1973; 30 BA Hulihan-Giblin (49_CR6) 1990; 252 MJ Marks (49_CR12) 1994; 63 KA Perkins (49_CR20) 1995; 118 MW Quick (49_CR22) 2002; 53 JA Rosecrans (49_CR24) 1993; 10 RD Schwartz (49_CR28) 1985; 45 KA Perkins (49_CR19) 1994; 270 X Zhang (49_CR35) 2000; 113 P Dobelis (49_CR3) 2002; 62 CI Bliss (49_CR1) 1967 MJ Marks (49_CR9) 1983; 224 OF Pomerleau (49_CR21) 1993; 61 JA Rosecrans (49_CR26) 1995; 37 MI Damaj (49_CR2) 1996; 277 JA Rosecrans (49_CR25) 1989; 79 LT Meltzer (49_CR13) 1981; 15 JL Wiley (49_CR34) 1996; 38 B Katz (49_CR8) 1957; 138 RJ Tallarida (49_CR33) 1986 A Nordberg (49_CR17) 1985; 16 M Zoli (49_CR36) 1998; 18 MJ Marks (49_CR11) 1993; 266 AH Mohammed (49_CR15) 2000; 113 2587745 - Prog Brain Res. 1989;79:239-48 7855204 - Psychopharmacology (Berl). 1994 Apr;114(3):456-62 8864050 - Behav Brain Res. 1996 Aug;78(2):183-8 8035180 - J Neurochem. 1994 Aug;63(2):561-9 7964732 - J Neurochem. 1994 Dec;63(6):2125-35 4064913 - Drug Alcohol Depend. 1985 Sep;16(1):9-17 8245270 - J Consult Clin Psychol. 1993 Oct;61(5):723-31 10942037 - Behav Brain Res. 2000 Aug;113(1-2):105-15 12436413 - J Neurobiol. 2002 Dec;53(4):457-78 13463799 - J Physiol. 1957 Aug 29;138(1):63-80 4009168 - J Neurochem. 1985 Aug;45(2):427-33 8071855 - J Pharmacol Exp Ther. 1994 Aug;270(2):628-38 12130686 - Mol Pharmacol. 2002 Aug;62(2):334-42 9614223 - J Neurosci. 1998 Jun 15;18(12):4461-72 2299587 - J Pharmacol Exp Ther. 1990 Jan;252(1):15-20 8437106 - J Pharmacol Exp Ther. 1993 Feb;264(2):542-52 4722204 - Psychopharmacologia. 1973 Jun 29;30(4):329-42 7620908 - Brain Res Bull. 1995;37(4):359-62 7291225 - Pharmacol Biochem Behav. 1981 Jul;15(1):21-6 8371136 - J Pharmacol Exp Ther. 1993 Sep;266(3):1268-76 10942030 - Behav Brain Res. 2000 Aug;113(1-2):35-41 4449931 - Psychopharmacologia. 1974;40(2):109-20 10366615 - J Neurosci. 1999 Jun 15;19(12):4804-14 12105111 - Ann N Y Acad Sci. 2002 Jun;965:354-63 8510190 - J Subst Abuse Treat. 1993 Mar-Apr;10(2):161-70 7617803 - Psychopharmacology (Berl). 1995 Mar;118(2):164-70 8613954 - J Pharmacol Exp Ther. 1996 Apr;277(1):454-61 1792691 - Trends Pharmacol Sci. 1991 Dec;12(12):467-73 3016239 - J Pharmacol Exp Ther. 1986 Aug;238(2):486-91 12829329 - Brain Res Mol Brain Res. 2003 Jun 10;114(2):172-6 2663167 - Cell Mol Neurobiol. 1989 Jun;9(2):141-78 1369662 - NIDA Res Monogr. 1991;(116):101-16 |
References_xml | – volume: 277 start-page: 454 year: 1996 ident: 49_CR2 publication-title: J Pharmacol Exp Ther – volume: 10 start-page: 161 year: 1993 ident: 49_CR24 publication-title: J Subst Abuse Treat doi: 10.1016/0740-5472(93)90041-Y – volume: 38 start-page: 222 year: 1996 ident: 49_CR34 publication-title: Drug Dev Res doi: 10.1002/(SICI)1098-2299(199607/08)38:3/4<222::AID-DDR11>3.0.CO;2-0 – volume: 15 start-page: 21 year: 1981 ident: 49_CR13 publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(81)90332-4 – volume: 114 start-page: 172 year: 2003 ident: 49_CR16 publication-title: Brain Res Mol Brain Res doi: 10.1016/S0169-328X(03)00171-2 – volume: 965 start-page: 354 year: 2002 ident: 49_CR14 publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2002.tb04177.x – volume: 9 start-page: 141 year: 1989 ident: 49_CR18 publication-title: Cell Mol Neurobiol doi: 10.1007/BF00713026 – volume: 266 start-page: 1268 year: 1993 ident: 49_CR11 publication-title: J Pharmacol Exp Ther – volume: 113 start-page: 105 year: 2000 ident: 49_CR35 publication-title: Behav Brain Res doi: 10.1016/S0166-4328(00)00205-9 – volume: 61 start-page: 723 year: 1993 ident: 49_CR21 publication-title: J Consult Clin Psychol doi: 10.1037/0022-006X.61.5.723 – volume-title: Statistics in biology year: 1967 ident: 49_CR1 – volume: 53 start-page: 457 year: 2002 ident: 49_CR22 publication-title: J Neurobiol doi: 10.1002/neu.10109 – volume: 116 start-page: 101 year: 1991 ident: 49_CR23 publication-title: NIDA Res Monogr – volume: 238 start-page: 486 year: 1986 ident: 49_CR29 publication-title: J Pharmacol Exp Ther – volume: 113 start-page: 35 year: 2000 ident: 49_CR15 publication-title: Behav Brain Res doi: 10.1016/S0166-4328(00)00198-4 – volume: 12 start-page: 467 year: 1991 ident: 49_CR31 publication-title: Trends Pharmacol Sci doi: 10.1016/0165-6147(91)90638-9 – volume: 79 start-page: 239 year: 1989 ident: 49_CR25 publication-title: Prog Brain Res doi: 10.1016/S0079-6123(08)62483-8 – volume: 252 start-page: 15 year: 1990 ident: 49_CR6 publication-title: J Pharmacol Exp Ther – volume: 114 start-page: 456 year: 1994 ident: 49_CR7 publication-title: Psychopharmacology doi: 10.1007/BF02249336 – volume: 118 start-page: 164 year: 1995 ident: 49_CR20 publication-title: Psychopharmacology (Berl) doi: 10.1007/BF02245835 – volume: 62 start-page: 334 year: 2002 ident: 49_CR3 publication-title: Mol Pharmacol doi: 10.1124/mol.62.2.334 – volume: 40 start-page: 109 year: 1974 ident: 49_CR5 publication-title: Psychopharmacologia (Berl) doi: 10.1007/BF00421360 – volume: 63 start-page: 561 year: 1994 ident: 49_CR27 publication-title: J Neurochem doi: 10.1046/j.1471-4159.1994.63020561.x – volume: 30 start-page: 329 year: 1973 ident: 49_CR32 publication-title: Psychopharmacologia doi: 10.1007/BF00429192 – volume: 18 start-page: 4461 year: 1998 ident: 49_CR36 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.18-12-04461.1998 – volume: 138 start-page: 63 year: 1957 ident: 49_CR8 publication-title: J Physiol (Lond) doi: 10.1113/jphysiol.1957.sp005838 – volume: 16 start-page: 9 year: 1985 ident: 49_CR17 publication-title: Drug Alcohol Depend doi: 10.1016/0376-8716(85)90077-8 – volume: 63 start-page: 2125 year: 1994 ident: 49_CR12 publication-title: J Neurochem doi: 10.1046/j.1471-4159.1994.63062125.x – volume: 78 start-page: 183 year: 1996 ident: 49_CR30 publication-title: Behav Brain Res doi: 10.1016/0166-4328(95)00245-6 – volume: 37 start-page: 359 year: 1995 ident: 49_CR26 publication-title: Brain Res Bull doi: 10.1016/0361-9230(95)00007-0 – volume: 45 start-page: 427 year: 1985 ident: 49_CR28 publication-title: J Neurochem doi: 10.1111/j.1471-4159.1985.tb04005.x – volume: 270 start-page: 628 year: 1994 ident: 49_CR19 publication-title: J Pharmacol Exp Ther – volume-title: Manual of pharmacology calculations with computer programs year: 1986 ident: 49_CR33 doi: 10.1007/978-1-4612-4974-0 – volume: 264 start-page: 542 year: 1993 ident: 49_CR10 publication-title: J Pharmacol Exp Ther – volume: 224 start-page: 806 year: 1983 ident: 49_CR9 publication-title: J Pharmacol Exp Ther – volume: 19 start-page: 4804 year: 1999 ident: 49_CR4 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.19-12-04804.1999 – reference: 4722204 - Psychopharmacologia. 1973 Jun 29;30(4):329-42 – reference: 12105111 - Ann N Y Acad Sci. 2002 Jun;965:354-63 – reference: 2663167 - Cell Mol Neurobiol. 1989 Jun;9(2):141-78 – reference: 10942037 - Behav Brain Res. 2000 Aug;113(1-2):105-15 – reference: 1369662 - NIDA Res Monogr. 1991;(116):101-16 – reference: 12130686 - Mol Pharmacol. 2002 Aug;62(2):334-42 – reference: 8510190 - J Subst Abuse Treat. 1993 Mar-Apr;10(2):161-70 – reference: 7620908 - Brain Res Bull. 1995;37(4):359-62 – reference: 2299587 - J Pharmacol Exp Ther. 1990 Jan;252(1):15-20 – reference: 3016239 - J Pharmacol Exp Ther. 1986 Aug;238(2):486-91 – reference: 7617803 - Psychopharmacology (Berl). 1995 Mar;118(2):164-70 – reference: 8371136 - J Pharmacol Exp Ther. 1993 Sep;266(3):1268-76 – reference: 2587745 - Prog Brain Res. 1989;79:239-48 – reference: 4009168 - J Neurochem. 1985 Aug;45(2):427-33 – reference: 8245270 - J Consult Clin Psychol. 1993 Oct;61(5):723-31 – reference: 7855204 - Psychopharmacology (Berl). 1994 Apr;114(3):456-62 – reference: 7964732 - J Neurochem. 1994 Dec;63(6):2125-35 – reference: 10942030 - Behav Brain Res. 2000 Aug;113(1-2):35-41 – reference: 13463799 - J Physiol. 1957 Aug 29;138(1):63-80 – reference: 4064913 - Drug Alcohol Depend. 1985 Sep;16(1):9-17 – reference: 9614223 - J Neurosci. 1998 Jun 15;18(12):4461-72 – reference: 8071855 - J Pharmacol Exp Ther. 1994 Aug;270(2):628-38 – reference: 12436413 - J Neurobiol. 2002 Dec;53(4):457-78 – reference: 8613954 - J Pharmacol Exp Ther. 1996 Apr;277(1):454-61 – reference: 8035180 - J Neurochem. 1994 Aug;63(2):561-9 – reference: 12829329 - Brain Res Mol Brain Res. 2003 Jun 10;114(2):172-6 – reference: 7291225 - Pharmacol Biochem Behav. 1981 Jul;15(1):21-6 – reference: 8437106 - J Pharmacol Exp Ther. 1993 Feb;264(2):542-52 – reference: 4449931 - Psychopharmacologia. 1974;40(2):109-20 – reference: 8864050 - Behav Brain Res. 1996 Aug;78(2):183-8 – reference: 10366615 - J Neurosci. 1999 Jun 15;19(12):4804-14 – reference: 1792691 - Trends Pharmacol Sci. 1991 Dec;12(12):467-73 |
SSID | ssj0000484 ssj0068394 |
Score | 1.9403086 |
Snippet | Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the... Issue Title: Nicotine Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine... Rationale: Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 306 |
SubjectTerms | Animals Brain - drug effects Brain Mapping Brain research Conditioning, Operant - drug effects Discrimination Learning - drug effects Down-Regulation - drug effects Drug dosages Drug Tolerance Laboratory animals Male Neurons - drug effects Nicotine Nicotine - pharmacology Rats Rats, Sprague-Dawley Receptors, Nicotinic - drug effects Reinforcement schedules Rubidium Radioisotopes - metabolism Toxicology |
Title | Evidence of cellular nicotinic receptor desensitization in rats exhibiting nicotine-induced acute tolerance |
URI | https://www.ncbi.nlm.nih.gov/pubmed/16010542 https://www.proquest.com/docview/218975208 https://www.proquest.com/docview/19287250 https://www.proquest.com/docview/67669026 https://www.proquest.com/docview/754557950 |
Volume | 184 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7aBEovoU1f27SpDiWHElGvZEvWqWRLllDIspQE9mZkPSA02Nvae8i_z4wfu_SwudgYS0ZoxtI3o5n5AL5OXapsNJ5b5QVPo5Pc5EZzr_PMROVcacmhf71QV7fpr1W2GmJzmiGsclwTu4Xa14585N9xKzI6E0n-Y_2XE2kUHa4ODBrP4XCKQISYG_RK7xbilHIw-weFQKCvyCwpnyzLxxPOpCsoKojjgMLYEDBz8_8etQd4dhvQ_BUcDciRXfSifg3PQnUML66Hs_FjOFv2VagfztnNLqmqOWdnbLmrT_3wBv6MTKKsjowc9xSJyipUiZayJBmugWGNpjjzlJlEMV19qia7qxjqS8MCkWrfUbz02CtwNO1RSTyzbtMG1tb3gRg7wlu4nV_e_LziA-cCdwhdWm5sqZwWiSudFEmqEa6I0msVojGhtFJanUYEmVEg1sPNT1tjfCA7p8yNl1a-g4OqrsIHYKIUdoqXNKIcsuCsVDH3XlAPlVs5gWSc5cINBcmJF-O-2JZS7gRToGAKEkxhJvBt22XdV-N4qvHJKLpi-DGbYqtGE_iyfYt_FM22rUK9aQrEvLlGZLi_hdJKGTReJ8D2tNAITDNt6CPve6XZjZdM4CwVH58c3gm87J09FDjzCQ7af5vwGeFPW552Sn4Khxfz2WyB99nlYvn7EW6bBRI |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXBOW1FKgP0AOqReokdnxACAHVlnarHrbS3oLjh7SiShaSFdofxX9kJo9dcdjeeokUxbYiz3jmG88L4O2xTaQJ2nEjneBJsDHXmVbcqSzVQVpbGLrQn1zI8VXyfZbOduDvkAtDYZWDTGwFtass3ZF_QFWkVSqi7NPiF6emUeRcHTpodFxx5ld_0GKrP55-RfK-E-Lk2_TLmPdNBbhF3dxwbQpplYhsYWMRJQr1sSickj5o7QsTx0YlAVFUEAhmULoro7XzBOSLTLvYxLjuHbibkIcRj4-aqY3gTyjns3uRCDy6CtAx5a-l2eBRjdoCpoJ6KlDYHAJ0rv_XiVuAbqvwTh7Bwx6pss8daz2GHV_uwb1J74vfg8PLrur16ohNN0lc9RE7ZJebetirJ_Bz6FzKqsDIUUCRr6xEFmwoK5OhzPULNP2Zo0woiiHrUkPZvGTInzXz1MR7TvHZwyzP56VDpnTM2GXjWVNde-oQ4p_C1a2Q4xnsllXpXwAThTDH-EgC0iH11sQyZM4JmiEzE48gGnY5t30BdOrDcZ2vSze3hMmRMDkRJtcjeL-esuiqf9w0eH8gXd4Lgjpfs-0IDtZf8QTTbpvSV8s6R4ydKUSi20dIJaVGY3kEbMsIhUA4VZoWed4xzeZ_yeROE_Hyxt87gPvj6eQ8Pz-9ONuHB91FEwXtvILd5vfSv0bo1RRvWoZn8OO2T9g_N189_Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB5RkFAvVUsfLLTFh5ZDhUVwEjs-oKotrKCU1aoCiVvq2I60KkoWklW1P7H_qjN57KqH5cYlUhTbijzjmc_2zHwAH45sJE2uHTfSCR7lNuQ60Yo7lcQ6l9Zmhg70L0fy7Dr6fhPfrMHfPheGwip7m9gYaldaOiM_RFekVSyC5DDvoiLGJ8PP0ztOBFJ00dqzaZiOZcEdN9XGuhyPCz__g7u56vj8BEX_UYjh6dW3M94RDnCLfrvm2mTSKhHYzIYiiBT6apE5JX2utc9MGBoV5YiwcoFABy2_Mlo7TyA_S7QLTYjjPoEN7KdxH7jx9XQ0_rl0CxFlhLYvEmFJWx86pOy2OOnvW4OmvKkgxgUKqkP4zvX_HnMFDG7c4fA5POtwLPvSKt4LWPPFFmxedjf1W7A_bmtizw_Y1TLFqzpg-2y8rJY9fwm_e15TVuaMrhEoLpYVqKA15WwytMh-Wpf3zFGeFEWYtYmjbFIw1N6KeaL4nlD0dt_L80nhUGUdM3ZWe1aXt574Q_wruH4UgbyG9aIs_DYwkQlzhI8oRznE3ppQ5olzgnrIxIQDCPpZTm1XHp1YOm7TRWHnRjApCiYlwaR6AJ8WXaZtbZCHGu_2oks7M1GlC6UewN7iK65vmm1T-HJWpYjAE4U4dXULqaTUuJUeAFvRQiFMjpWmQd60SrP8X9qQx5HYefD39mATV1v643x0sQtP21Moiuh5C-v1_cy_Q1xWZ-87jWfw67EX2T9u8EjY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evidence+of+cellular+nicotinic+receptor+desensitization+in+rats+exhibiting+nicotine-induced+acute+tolerance&rft.jtitle=Psychopharmacology&rft.au=Robinson%2C+Susan+E&rft.au=James%2C+John+R&rft.au=Lapp%2C+Laura+N&rft.au=Vann%2C+Robert+E&rft.date=2006-02-01&rft.issn=0033-3158&rft.volume=184&rft.issue=3-4&rft.spage=306&rft_id=info:doi/10.1007%2Fs00213-005-0049-9&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon |